![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2016
Brenner, C.; Adrion, Christine 
ORCID: https://orcid.org/0000-0003-2408-2533; Grabmaier, U.; Theisen, D.; Ziegler, F. von; Leber, A.; Becker, A.; Sohn, H. Y.; Hoffmann, E.; Mansmann, Ulrich; Steinbeck, G.; Franz, W. M. und Theiss, H. D.
(2016):
Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).
In: International Journal of Cardiology, Bd. 205: S. 23-30
ORCID: https://orcid.org/0000-0003-2408-2533; Grabmaier, U.; Theisen, D.; Ziegler, F. von; Leber, A.; Becker, A.; Sohn, H. Y.; Hoffmann, E.; Mansmann, Ulrich; Steinbeck, G.; Franz, W. M. und Theiss, H. D.
(2016):
Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).
In: International Journal of Cardiology, Bd. 205: S. 23-30
2009
Lehrke, M.; Becker, A.; Greif, M.; Stark, R.; Laubender, Rüdiger P.; Ziegler, F. von; Lebherz, C.; Tittus, J.; Reiser, M.; Becker, C.; Göke, Burkhard; Leber, A.; Parhofer, K. G. und Broedl, U. C.
(2009):
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.
In: European Journal of Endocrinology, Bd. 161, Nr. 2: S. 339-344